Dunlap Ryan 4
4 · CytoDyn Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Dunlap Ryan
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2022-09-06+185,333→ 185,333 totalExercise: $0.50Exp: 2032-09-06→ Common Stock (185,333 underlying)
Footnotes (1)
- [F1]The options will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.